Imovax rabies vaccine vials

Ended Awarded

Contract number
SPE2DR26FFRM8
Awardee
Awarding agency
Obligated
$13,835

Award facts

Contract value 100% obligated
$13,834.70 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $13,834.70 delivery order to DMS Pharmaceutical Group Inc. on July 2, 2026, for Imovax Rabies vaccine vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical is a woman-owned small business headquartered in Park Ridge, Illinois, and holds the sole regional prime vendor contract under PPV-G GEN V, a $499.999 billion indefinite delivery contract (SPE2DX) awarded November 13, 2025, with a completion date of December 31, 2036. Place of performance is Park Ridge, IL. The order has a firm fixed price and an ultimate completion date of July 6, 2026.

Quick answers

Who was awarded contract SPE2DR26FFRM8?

SPE2DR26FFRM8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 2, 2026.

How much is contract SPE2DR26FFRM8 worth?

The government has obligated $13,835 on SPE2DR26FFRM8.

Is contract SPE2DR26FFRM8 an order under another contract?

Yes. SPE2DR26FFRM8 is a delivery order under SPE2DR25D9242, an indefinite delivery contract.

Was contract SPE2DR26FFRM8 competed?

The extent of competition for SPE2DR26FFRM8 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award